These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 10510847)

  • 1. Bioconjugation in pharmaceutical chemistry.
    Veronese FM; Morpurgo M
    Farmaco; 1999 Aug; 54(8):497-516. PubMed ID: 10510847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAFT Polymer-Antibody Conjugation: Squaramide Ester Chemistry Leads to Conjugates with a Therapeutic Anti-EGFR Antibody with Full Retention of Activity and Increased Tumor Uptake
    Ardana A; Ghosh S; Huda P; Fletcher NL; Thurecht KJ; Williams CC
    Mol Pharm; 2023 Jun; 20(6):3073-3087. PubMed ID: 37218930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable amphiphilic polymer-drug conjugate micelles.
    Hu X; Jing X
    Expert Opin Drug Deliv; 2009 Oct; 6(10):1079-90. PubMed ID: 19645633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer-drug conjugates: present state of play and future perspectives.
    Pang X; Du HL; Zhang HQ; Zhai YJ; Zhai GX
    Drug Discov Today; 2013 Dec; 18(23-24):1316-22. PubMed ID: 24055841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled Radical Polymerization as an Enabling Approach for the Next Generation of Protein-Polymer Conjugates.
    Pelegri-O'Day EM; Maynard HD
    Acc Chem Res; 2016 Sep; 49(9):1777-85. PubMed ID: 27588677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-Polymer Conjugates Synthesized Using Water-Soluble Azlactone-Functionalized Polymers Enable Receptor-Specific Cellular Uptake toward Targeted Drug Delivery.
    Kim JS; Sirois AR; Vazquez Cegla AJ; Jumai'an E; Murata N; Buck ME; Moore SJ
    Bioconjug Chem; 2019 Apr; 30(4):1220-1231. PubMed ID: 30920802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer-drug conjugates for novel molecular targets.
    Sanchis J; Canal F; Lucas R; Vicent MJ
    Nanomedicine (Lond); 2010 Aug; 5(6):915-35. PubMed ID: 20735226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymer-protein and polymer-drug conjugates in cancer therapy.
    Thanou M; Duncan R
    Curr Opin Investig Drugs; 2003 Jun; 4(6):701-9. PubMed ID: 12901229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing polymer conjugates as lysosomotropic nanomedicines.
    Duncan R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphiphilic drug-peptide-polymer conjugates based on poly(ethylene glycol) and hyperbranched polyglycerol for epidermal growth factor receptor targeting: the effect of conjugate aggregation on in vitro activity.
    Pethő L; Kasza G; Lajkó E; Láng O; Kőhidai L; Iván B; Mező G
    Soft Matter; 2020 Jun; 16(24):5759-5769. PubMed ID: 32530018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological effects of soluble synthetic polymers as drug carriers.
    Duncan R
    Crit Rev Ther Drug Carrier Syst; 1985; 1(4):281-310. PubMed ID: 3913527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer conjugates: nanosized medicines for treating cancer.
    Vicent MJ; Duncan R
    Trends Biotechnol; 2006 Jan; 24(1):39-47. PubMed ID: 16307811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer Drug Conjugates: Recent Advancements in Various Diseases.
    Singh J; Desai S; Yadav S; Narasimhan B; Kaur H
    Curr Pharm Des; 2016; 22(19):2821-43. PubMed ID: 26898741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms.
    Clementi C; Miller K; Mero A; Satchi-Fainaro R; Pasut G
    Mol Pharm; 2011 Aug; 8(4):1063-72. PubMed ID: 21608527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-polymer conjugation-moving beyond PEGylation.
    Qi Y; Chilkoti A
    Curr Opin Chem Biol; 2015 Oct; 28():181-93. PubMed ID: 26356631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextran conjugates in drug delivery.
    Varshosaz J
    Expert Opin Drug Deliv; 2012 May; 9(5):509-23. PubMed ID: 22432550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymer-drug conjugates: current status and future trends.
    Greco F; Vicent MJ
    Front Biosci; 2008 Jan; 13():2744-56. PubMed ID: 17981750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent development of poly(ethylene glycol)-cholesterol conjugates as drug delivery systems.
    He ZY; Chu BY; Wei XW; Li J; Edwards CK; Song XR; He G; Xie YM; Wei YQ; Qian ZY
    Int J Pharm; 2014 Jul; 469(1):168-78. PubMed ID: 24768727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.